Back

First in-vivo metabolic signature of mitochondrial oxidative failure driving infantile Alstrom-related dilated cardiomyopathy

9 May 2026 (15:06 - 15:15)
Organised by: Logo
Congress Presentation Part of: When systemic and genetic disease affects the heart Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Alberto Guarnaccia

Madonna della Salute C.D.C Health Centre, Porto Viro (Italy)

4 More presentations in this session

Presentation thumbnail
Dilated cardiomyopathy in Becker muscular dystrophy: therapeutic limits and opportunities in advanced heart failure
Doctor C. Cestie (Rome, IT)
Slides Video
Presentation thumbnail
Burning down the powerhouse: raising a red flag
Miss A. Trezza (Milan, IT)
Slides Video
Presentation thumbnail
Early systolic dysfunction in a patient with neuromuscular disease: diagnostic and therapeutic challenges
Doctor R. Esculudes Dos Santos Ferrao Gomes (Lisboa, PT)
Slides Video
Presentation thumbnail
Danon disease presenting with severe rapidly progressive cardiomyopathy in a young paediatric male patient
Doctor R. Esculudes Dos Santos Ferrao Gomes (Lisboa, PT)
Slides Video

Access the full session

Session thumbnail
When systemic and genetic disease affects the heart
Video

The Event

Event poster

Heart Failure 2026

9 May 2026 15:06 CET
You may be interested in
thumbnail
Congress Session
The uncharted territory of rare cardiomyopathies
12 December 2025
thumbnail
Congress Session
What fuels the heart matters
21 May 2022
thumbnail
Congress Session
Molecular mechanisms and therapeutic targets in cardiomyopathy
31 August 2025
thumbnail
Congress Presentation
Casos clinicos 1.
23 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources